The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings-Reference-Cited by-同舟云学术

The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings

Published:2021-06-25 Issue:1 Volume:16 Page:130-147
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Shor Ryann E.¹,Dai Jinxiang¹,Lee Sun‐Young²,Pisarsky Laura¹,Matei Irina³,Lucotti Serena³,Lyden David³,Bissell Mina J.²,Ghajar Cyrus M.¹⁴^ORCID

Affiliation:

1. Public Health Sciences Division/Translational Research Program Fred Hutchinson Cancer Research Center Seattle WA USA

2. Biological Systems and Engineering Division Lawrence Berkeley National Laboratory CA USA

3. Children’s Cancer and Blood Foundation Laboratories Department of Pediatrics, and Cell and Developmental Biology Drukier Institute for Children’s Health Meyer Cancer Center Weill Cornell Medicine New York NY USA

4. Human Biology Division Fred Hutchinson Cancer Research Center Seattle WA USA

Funder

Breast Cancer Research Foundation

U.S. Department of Defense

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13031

Reference60 articles.

1. Dormancy of Mammary Carcinoma After Mastectomy